Earnings Call · Q4 FY2025·2026-02-13

Q4 25EPS +20.08%·Rev n/aQ3 25EPS +76.39%·Rev n/aQ2 25EPS +29.00%·Rev n/aQ1 25EPS +18.97%·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel — Chief Executive Officer

James Mock — Chief Financial Officer

Stephen Hoge — President

+5.3%1d on move date+5.2% vs SPY3d+16.2%5d+24.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access